Viridian Therapeutics (VRDN) Short Interest Ratio & Short Volume $21.30 +0.30 (+1.44%) As of 11:25 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viridian Therapeutics Short Interest DataViridian Therapeutics (VRDN) has a short interest of 11.00 million shares. This marks a -4.93% decrease in short interest from the previous month. The short interest ratio (days to cover) is 14.4, indicating that it would take 14.4 days of the average trading volume of 868,484 shares to cover all short positions.Current Short Interest11,000,000 sharesPrevious Short Interest11,570,000 sharesChange Vs. Previous Month-4.93%Dollar Volume Sold Short$198.11 millionShort Interest Ratio14.4 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares81,670,000 sharesPercentage of Shares Shorted13.47%Today's Trading Volume76,595 sharesAverage Trading Volume868,484 sharesToday's Volume Vs. Average9% Short Selling Viridian Therapeutics? Sign up to receive the latest short interest report for Viridian Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRDN Short Interest Over TimeVRDN Days to Cover Over TimeVRDN Percentage of Float Shorted Over Time Viridian Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202511,000,000 shares $198.11 million -4.9%N/A14.4 $18.01 8/31/202511,570,000 shares $212.66 million -1.9%14.4%14.5 $18.38 8/15/202511,790,000 shares $218.59 million +0.9%N/A15.3 $18.54 7/31/202511,680,000 shares $204.63 million +0.3%14.5%15.6 $17.52 7/15/202511,640,000 shares $189.27 million +576.7%N/A15.8 $16.26 6/30/20251,720,000 shares $24.05 million -84.8%2.1%3.9 $13.98 6/15/202511,340,000 shares $180.08 million +6.0%14.1%13 $15.88 5/31/202510,700,000 shares $147.55 million +1.4%13.6%12.5 $13.79 5/15/202510,550,000 shares $133.14 million +4.3%13.4%11.7 $12.62 4/30/202510,120,000 shares $137.13 million -8.3%N/A10.9 $13.55 Get the Latest News and Ratings for VRDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/202511,040,000 shares $141.31 million +8.7%14.0%11.5 $12.80 3/31/202510,160,000 shares $136.96 million +1.6%12.9%10.1 $13.48 3/15/202510,000,000 shares $159.20 million +4.5%12.7%9.1 $15.92 2/28/20259,570,000 shares $148.62 million -1.8%12.2%7.4 $15.53 2/15/20259,740,000 shares $159.74 million -10.5%12.4%7.6 $16.40 1/31/202510,880,000 shares $210.85 million -6.5%N/A7.8 $19.38 1/15/202511,630,000 shares $202.25 million -3.5%N/A8.7 $17.39 12/31/202412,050,000 shares $231.00 million +28.9%N/A9.3 $19.17 12/15/20249,350,000 shares $166.90 million +6.9%N/A7.4 $17.85 11/30/20248,750,000 shares $188.56 million -3.9%N/A5.8 $21.55 11/15/20249,100,000 shares $183.27 million -9.2%N/A5.9 $20.14 10/31/202410,020,000 shares $216.13 million +2.4%N/A7.2 $21.57 10/15/20249,790,000 shares $235.35 million -3.6%N/A6.8 $24.04 9/30/202410,150,000 shares $230.91 million -3.0%N/A6.8 $22.75 9/15/202410,460,000 shares $230.75 million +30.3%N/A7.2 $22.06 8/31/20248,030,000 shares $117.88 million +0.4%N/A5.9 $14.68 8/15/20248,000,000 shares $119.36 million -5.8%N/A7.8 $14.92 7/31/20248,490,000 shares $143.06 million -1.6%N/A8 $16.85 7/15/20248,630,000 shares $126.77 million +9.0%N/A8.6 $14.69 6/30/20247,920,000 shares $103.04 million -15.7%N/A8.4 $13.01 6/15/20249,390,000 shares $116.81 million -2.7%N/A10.1 $12.44 5/31/20249,650,000 shares $115.32 million -1.5%N/A10.3 $11.95 5/15/20249,800,000 shares $139.85 million +5.3%N/A10.5 $14.27 4/30/20249,310,000 shares $123.45 million -4.3%N/A10.2 $13.26 4/15/20249,730,000 shares $152.18 million +2.8%N/A10.8 $15.64 3/31/20249,470,000 shares $165.82 million +24.3%N/A9.8 $17.51 3/15/20247,620,000 shares $130.23 million +0.7%N/A7.8 $17.09 2/29/20247,570,000 shares $141.63 million -2.3%N/A7.9 $18.71 2/15/20247,750,000 shares $149.03 million -8.0%N/A8.5 $19.23 1/31/20248,420,000 shares $162.09 million +4.0%N/A9.2 $19.25 1/15/20248,100,000 shares $179.33 million -6.4%N/A8.6 $22.14 12/31/20238,650,000 shares $188.40 million +2.3%N/A9.5 $21.78 12/15/20238,460,000 shares $162.60 million -0.5%N/A9.7 $19.22 11/30/20238,500,000 shares $142.29 million +2.7%N/A10.9 $16.74 11/15/20238,280,000 shares $132.31 million +1.5%N/A11 $15.98 10/31/20238,160,000 shares $102 million +6.8%N/A11.6 $12.50 10/15/20237,640,000 shares $94.28 million -19.1%N/A11.9 $12.34 9/30/20239,440,000 shares $144.81 million +1.1%N/A13.4 $15.34 9/15/20239,340,000 shares $163.73 million -1.3%N/A13.4 $17.53 8/31/20239,460,000 shares $171.89 million +9.2%N/A12.7 $18.17 8/15/20238,660,000 shares $169.39 million +39.2%N/A11.7 $19.56 7/31/20236,220,000 shares $116.69 million -17.0%N/A7.8 $18.76 7/15/20237,490,000 shares $166.43 million +11.0%N/A9.7 $22.22 6/30/20236,750,000 shares $160.58 million +11.2%N/A9.1 $23.79 6/15/20236,070,000 shares $169.17 million +6.7%N/A9.3 $27.87 5/31/20235,690,000 shares $135.59 million +30.5%N/A9.5 $23.83 5/15/20234,360,000 shares $102.15 million +24.9%N/A7.2 $23.43 4/30/20233,490,000 shares $97.82 million -1.7%N/A6.2 $28.03 4/15/20233,550,000 shares $89.46 million +2.9%N/A6.7 $25.20 3/31/20233,450,000 shares $87.77 million +24.1%N/A5.9 $25.44 3/15/20232,780,000 shares $79.15 million +4.5%N/A5 $28.47 2/28/20232,660,000 shares $87.14 million No ChangeN/A4.6 $32.76 2/15/20232,660,000 shares $86.88 million +12.2%N/A4.2 $32.66 1/31/20232,370,000 shares $86.55 million -3.3%N/A3.7 $36.52 1/15/20232,450,000 shares $88.76 million -11.2%N/A3.9 $36.23 12/30/20222,760,000 shares $80.62 million +13.6%N/A4.5 $29.21 12/15/20222,430,000 shares $66.80 million -16.5%N/A4.4 $27.49 11/30/20222,910,000 shares $73.54 million +2.8%N/A5.6 $25.27 11/15/20222,830,000 shares $64.65 million +25.2%N/A6 $22.85 10/31/20222,260,000 shares $44.97 million +1.4%N/A2.8 $19.90 10/15/20222,230,000 shares $46.76 million +5.2%N/A2.8 $20.97 9/30/20222,120,000 shares $43.48 million +11.0%N/A2.8 $20.51 9/15/20221,910,000 shares $43.68 million +34.5%N/A2.4 $22.87 8/31/20221,420,000 shares $31.54 million -44.3%N/A1.8 $22.21 8/15/20222,550,000 shares $56.10 million -2.7%N/A3.6 $22.00 7/31/20222,620,000 shares $34.69 million -0.8%N/A7.5 $13.24 7/15/20222,640,000 shares $35.56 million +12.3%N/A7.9 $13.47 6/30/20222,350,000 shares $27.19 million +34.3%N/A7.1 $11.57 6/15/20221,750,000 shares $18.22 million +17.5%N/A5.7 $10.41 5/31/20221,490,000 shares $18.18 million +11.2%N/A7.3 $12.20 5/15/20221,340,000 shares $18.12 million +62.7%N/A7.4 $13.52 4/30/2022823,500 shares $11.33 million +54.4%N/A5.7 $13.76 4/15/2022533,300 shares $10.12 million +6.5%N/A4.6 $18.97 3/31/2022500,900 shares $9.26 million -7.0%N/A5 $18.49 3/15/2022538,700 shares $10.73 million +26.2%N/A6.3 $19.91 2/28/2022426,800 shares $7.71 million +25.7%N/A4.2 $18.07 2/15/2022339,500 shares $6.92 million -2.5%N/A3.6 $20.37 1/31/2022348,300 shares $7.00 million +2.8%N/A3.7 $20.10 1/15/2022338,800 shares $6.78 million +2.1%N/A3.4 $20.00 12/31/2021332,000 shares $6.56 million +43.9%N/A2.6 $19.77 12/15/2021230,700 shares $4.74 million +45.0%N/A1.6 $20.54 11/30/2021159,100 shares $3.06 million +12.4%N/A0.7 $19.24 11/15/2021141,500 shares $2.71 million +6.4%N/A0.6 $19.14 10/29/2021133,000 shares $2.41 million -12.5%N/A0.5 $18.10 10/15/2021152,000 shares $2.59 million +4.3%N/A0.6 $17.07 9/30/2021145,800 shares $2.40 million +172.0%N/A0.7 $16.45 9/15/202153,600 shares $636.77 thousand -3.4%0.8%0.3 $11.88 8/31/202155,500 shares $742.59 thousand -15.5%0.9%0.9 $13.38 8/13/202165,700 shares $773.29 thousand -12.3%N/A1.5 $11.77 7/30/202174,900 shares $1.16 million -5.4%1.0%3 $15.52 7/15/202179,200 shares $1.43 million -1.9%1.1%2.4 $18.11 6/30/202180,700 shares $1.48 million -7.8%1.1%2.3 $18.29 6/15/202187,500 shares $1.58 million +23.6%1.2%2.3 $18.00 5/28/202170,800 shares $1.28 million -39.7%1.0%2.1 $18.01 5/14/2021117,500 shares $2.06 million +38.7%1.7%3.3 $17.52 4/30/202184,700 shares $1.51 million -24.0%1.5%2.3 $17.84 4/15/2021111,500 shares $1.61 million +18.4%1.9%3 $14.46 3/31/202194,200 shares $1.57 million -22.2%2.0%1.7 $16.64 3/15/2021121,000 shares $2.18 million No Change4.7%2 $18.00 2/26/2021121,000 shares $2.05 million -19.7%5.0%1.6 $16.98 2/12/2021150,600 shares $2.82 million +1.1%6.2%1.6 $18.74 1/29/2021149,000 shares $2.66 million -11.1%6.1%1.2 $17.88 1/15/2021167,600 shares $3.28 million No Change6.3%0.4 $19.59 VRDN Short Interest - Frequently Asked Questions What is Viridian Therapeutics' current short interest? Short interest is the volume of Viridian Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 11,000,000 shares of VRDN short. Learn More on Viridian Therapeutics' current short interest. What is a good short interest ratio for Viridian Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRDN shares currently have a short interest ratio of 14.0. Learn More on Viridian Therapeutics's short interest ratio. Which institutional investors are shorting Viridian Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Viridian Therapeutics: Group One Trading LLC, and Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Viridian Therapeutics' short interest increasing or decreasing? Viridian Therapeutics saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 11,000,000 shares, a decrease of 4.9% from the previous total of 11,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Viridian Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "healthcare" compare to Viridian Therapeutics: RadNet, Inc. (8.36%), BrightSpring Health Services, Inc. (15.80%), Sotera Health Company (5.06%), Option Care Health, Inc. (3.46%), GeneDx Holdings Corp. (14.35%), Heartflow, Inc. (1.11%), Privia Health Group, Inc. (2.87%), Veracyte, Inc. (11.87%), Surgery Partners, Inc. (17.40%), Concentra Group Holdings Parent, Inc. (3.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Viridian Therapeutics stock? Short selling VRDN is an investing strategy that aims to generate trading profit from Viridian Therapeutics as its price is falling. VRDN shares are trading up $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Viridian Therapeutics? A short squeeze for Viridian Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VRDN, which in turn drives the price of the stock up even further. How often is Viridian Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRDN, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies RadNet Short Interest Data BrightSpring Health Services Short Interest Data Sotera Health Short Interest Data Option Care Health Short Interest Data GeneDx Short Interest Data Heartflow Short Interest Data Privia Health Group Short Interest Data Veracyte Short Interest Data Surgery Partners Short Interest Data Concentra Group Holdings Parent Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRDN) was last updated on 10/8/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
